SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-21-002229
Filing Date
2021-02-08
Accepted
2021-02-08 16:23:48
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 navb20210207_s3.htm S-3 371516
2 EXHIBIT 4.6 ex_224977.htm EX-4.6 494996
3 EXHIBIT 5.1 ex_224978.htm EX-5.1 23564
4 EXHIBIT 23.2 ex_224979.htm EX-23.2 3045
5 letterheadb.jpg GRAPHIC 4589
6 letterheadlogo01.jpg GRAPHIC 12962
7 letterheadlogo02.jpg GRAPHIC 12623
8 navb20210207_s3img001.jpg GRAPHIC 3537
  Complete submission text file 0001437749-21-002229.txt   941154
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252847 | Film No.: 21601689
SIC: 2835 In Vitro & In Vivo Diagnostic Substances